An Early Phase 2 Clinical Study of KSP-0243

Clinical trial NCT05831670 · COMPLETED

Trial details

NCT number: NCT05831670
Sponsor: Kissei Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2023-04-27
Primary completion: 2024-10-18
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.